Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06291597

Vaping Adverse Lung and Heart Events Cohort

VapALERT: A Prospective, Exploratory and Adaptive Cohort Study to Identify Symptomatic and Asymptomatic Pulmonary and Cardiovascular Effects of Vaping

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Laval University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This prospective study assesses the pulmonary and cardiovascular effets of vaping in adult electronic cigarette users with biannual visits and a 5-year follow-up.

Detailed description

Daily vaping device users will be recruited in the Quebec City metropolitan area. Subjects will be asked to perform pulmonary function tests (spirometry, oscillometry, plethysmography, methacholine provocation) every 6 months for a 5-year follow up. Subjects will also answer a questionnaire assessing their vaping, tobacco and cannabis smoking habits, as well as their perceived respiratory symptoms. Blood draws and sputum inductions will be performed for cell counts and to measure inflammation markers.

Conditions

Interventions

TypeNameDescription
OTHERVapingParticipants use their vaping products at their own discretion and their intake is monitored via questionnaires.

Timeline

Start date
2021-10-14
Primary completion
2031-12-01
Completion
2032-06-01
First posted
2024-03-04
Last updated
2024-03-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06291597. Inclusion in this directory is not an endorsement.

Vaping Adverse Lung and Heart Events Cohort (NCT06291597) · Clinical Trials Directory